SEE
56
6
LMT
34
2
LLY
37
-3
CAH
48
-5
PFG
45
3
NEE
50
-5
GS
75
2
GOOG
50
-3
DE
63
3
FTI
81
5
XRX
44
3
USB
55
-6
APD
59
2
NRG
49
-3
FITB
63
3
HSIC
56
5
EFX
38
2
PSX
47
2
TGT
22
2
WDC
47
4
SEE
56
6
LMT
34
2
LLY
37
-3
CAH
48
-5
PFG
45
3
NEE
50
-5
GS
75
2
GOOG
50
-3
DE
63
3
FTI
81
5
XRX
44
3
USB
55
-6
APD
59
2
NRG
49
-3
FITB
63
3
HSIC
56
5
EFX
38
2
PSX
47
2
TGT
22
2
WDC
47
4
Financhill
Back

ZyVersa Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
8

ZVSA
ZyVersa Therapeutics

Last Price:
1.12
Seasonality Move:
-78.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

ZyVersa Therapeutics Price Quote

$1.12
-0.01 (-1.75%)
(Updated: November 23, 2024 at 6:02 AM ET)

ZyVersa Therapeutics Key Stats

Sell
8
ZyVersa Therapeutics (ZVSA) is a Sell
Day range:
$1.06 - $1.13
52-week range:
$1.04 - $42.39
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.38%
Volume:
132.6K
Avg. volume:
2.6M
1-year change:
-96.06%
Market cap:
$2.6M
Revenue:
$0
EPS:
$-113.75

How Much Does ZyVersa Therapeutics Make?

Data Unavailable

Is ZyVersa Therapeutics Growing As A Company?

Data Unavailable

ZyVersa Therapeutics Stock Price Performance

What Is ZyVersa Therapeutics 52-Week High & Low?

ZyVersa Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy ZyVersa Therapeutics?

Is ZyVersa Therapeutics Cash Flow Positive?

  • What Is ZVSA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$9.1M
  • What Is ZyVersa Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $7.7M
  • What Is ZyVersa Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

ZyVersa Therapeutics Return On Invested Capital

Data Unavailable

ZyVersa Therapeutics Earnings Date & Stock Price

ZyVersa Therapeutics Competitors

  • Who Are ZyVersa Therapeutics's Competitors?
    Below is a list of companies who compete with ZyVersa Therapeutics or are related in some way:
    • Cognition Therapeutics Inc (CGTX)
    • Dermata Therapeutics Inc (DRMA)
    • NovaBay Pharmaceuticals Inc (NBY)
    • NeuroBo Pharmaceuticals Inc (NRBO)
    • Palatin Technologies Inc (PTN)

ZyVersa Therapeutics Dividend Yield

ZyVersa Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -51.88%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 20.00
Upside from Last Price: 1669.91%

Major Shareholders

  • How many ZVSA shares are owned by institutional investors?
    15.4K ZVSA shares are owned by institutional investors
  • How many ZVSA shares are owned by insiders?
    537.6K ZVSA shares are owned by insiders